Skip to main content

Year: 2020

Arco Vara`s financial calendar for 2021

In 2021, Arco Vara will release its consolidated financial reports on the following dates:11.02.2021: Q4 2020 unaudited interim report01.04.2021: 2020 audited annual report29.04.2021: Q1 2021 unaudited interim report29.07.2021: Q2 2021 unaudited interim report28.10.2021: Q3 2021 unaudited interim report.Tiina MalmCFOArco Vara ASTel: +372 614 4630tiina.malm@arcovara.com

Continue reading

Arco Vara AS-i 2021. aasta finantskalender

Arco Vara AS avaldab 2021. aastal konsolideeritud finantstulemused järgmistel kuupäevadel:11.02.2021: 2020. aasta IV kvartali auditeerimata vahearuanne01.04.2021: 2020. majandusaasta auditeeritud aruanne29.04.2021: 2021. aasta I kvartali auditeerimata vahearuanne29.07.2021: 2021. aasta II kvartali auditeerimata vahearuanne28.10.2021: 2021. aasta III kvartali auditeerimata vahearuanne.Tiina MalmFinantsjuhtArco Vara ASTel: +372 614 4630tiina.malm@arcovara.com

Continue reading

Baozun to Announce Third Quarter 2020 Unaudited Financial Results on November 23, 2020

SHANGHAI, China, Nov. 09, 2020 (GLOBE NEWSWIRE) — Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) (“Baozun” or the “Company”), the leading brand e-commerce service partner that helps brands execute their e-commerce strategies in China, today announced that it will release its unaudited financial results for the third quarter ended September 30, 2020, on Monday, November 23, 2020, before the open of U.S. markets.The Company will host a conference call to discuss the earnings at 7:00 a.m. Eastern Time on Monday, November 23, 2020 (8:00 p.m. Beijing time on the same day).Due to the outbreak of COVID-19, operator assisted conference calls are not available at the moment. All participants wishing to attend the call must preregister online before they can receive the dial-in numbers. Preregistration may require a few minutes...

Continue reading

Southside Bancshares, Inc. Announces Completion of Private Placement of $100.0 Million of 3.875% Fixed-to-Floating Rate Subordinated Notes

TYLER, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) — Southside Bancshares, Inc. (the “Company”) (NASDAQ:SBSI), the parent company of Southside Bank, announced today the completion of its private placement of $100.0 million in fixed-to-floating rate subordinated notes due 2030 (the “Notes”) on November 6, 2020. The Notes bear interest at a fixed rate of 3.875% for the first five years, and the interest rate will reset quarterly thereafter to the then current three-month Secured Overnight Financing Rate, as published by the Federal Reserve Bank of New York, plus 366 basis points. The Company is entitled to redeem the Notes, in whole or in part, on any interest payment date on or after November 15, 2025, or at any time, in whole but not in part, upon certain other specified events.The Notes are intended to qualify as Tier 2 capital for the...

Continue reading

Party City Announces Third Quarter 2020 Financial Results; Total Revenue for Fiscal October 2020

Total Sales of $533.8 million for Third Quarter; Brand comparable sales growth of 8.3%, highest in 9 years Net Income of $239.7 Million; Adjusted EBITDA of $49.2 million up 187% from Third Quarter 2019Better Than Expected Halloween and October PerformanceELMSFORD, N.Y., Nov. 09, 2020 (GLOBE NEWSWIRE) — Party City Holdco Inc. (the “Company” or “PRTY”; NYSE:PRTY) today announced financial results for the third quarter ended September 30, 2020, as well as total revenue for fiscal October 2020.Brad Weston, Chief Executive Officer, stated, “We are very pleased with our better than expected third quarter performance, highlighted by the continued strength in our core business. Against a pandemic-impacted environment, we delivered $534 million in sales, including an 8.3% brand comparable sales increase, a stabilization in our Wholesale...

Continue reading

Dermatitis Drugs Market to Witness a Staggering 10.2% CAGR and Hit USD 13,630.8 Million by 2026; Increasing Approval of Novel Therapies Will Favor Growth, says Fortune Business Insights

Pune, Nov. 09, 2020 (GLOBE NEWSWIRE) — The global dermatitis drugs market size will expand considerably in the coming years driven by the advancements across numerous drug classes. According to a report published by Fortune Business Insights, titled “Dermatitis Drugs: Global Market Analysis, Insights And Forecast, 2019-2026,” the market was valued at US$ 6,097.4 Mn in 2018. Fortune Business Insights predicts that the market will rise impressively at a CAGR of 10.2% and reach US$ 13,630.8 Mn by the end of 2026.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dermatitis-drugs-market-100658Topical Treatment for Atopic Dermatitis gets FDA Nod, Subsequently Aiding the Market’s ExpansionThe global dermatitis drugs market will derive significant growth from increasing usage...

Continue reading

Change of ownership / shares in RIAS

Change of ownership / shares in RIASIn accordance with the Capital Markets Act section 30, cf. section 38, we can hereby inform that SmallCap Danmark A/S after the sale of shares in RIAS today, owns 45,859 B-shares, corresponding to 19.9% of the share capital and 8.9% of the voting rights in RIAS A/S.

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.